By: ICN Bureau
Last updated : October 23, 2026 5:22 pm
The session features a stellar lineup of thought leaders across academia, research, and corporate R&D: Dr. Rahul Nabar, Adjunct Professor, Department of Chemical Engineering, IIT Bombay; Janak Nabar, Chief Executive Officer, Centre for Technology, Innovation and Economic Research (CTIER); Dr. Jagannath Jadhav, Assistant Vice President (R&D and Business Development), Indo Amines; Dr. Maneesh Kumar Sharma, Associate Vice President - NPD/R&D, Silox India and Dr. Akshay Kant Chaturvedi, Corporate Head – IPR, Gujarat Fluorochemicals
In a bid to propel India’s HardTech and chemical innovation ecosystem toward the vision of a developed nation, India Chemical News and Indian Pharma Post will host a crucial panel discussion titled "Viksit Bharat 2047: Structuring Capitals, Grants, and IP Protection to Scale". The session is scheduled to take place on October 28, 2026, as part of the prestigious 'ChemPharma R&D Summit 2026’. The Summit is scheduled to take place on October 27–28, 2026, at the Courtyard by Marriott Mumbai International Airport, Mumbai.
The agenda of the Summit is available Here. One can register on the below given Link:
https://www.indianchemicalnews.com/chempharma_r_and_d_summit_2026//register.php
As India targets complete economic and technological transformation by 2047, the session will address critical structural bottlenecks in financing, intellectual property, and commercialization within the chemical and pharmaceutical industries. Industry experts and academics will converge to deliberate on creating a robust framework capable of scaling deep-tech advancements.
The session features a stellar lineup of thought leaders across academia, research, and corporate R&D: Dr. Rahul Nabar, Adjunct Professor, Department of Chemical Engineering, IIT Bombay; Janak Nabar, Chief Executive Officer, Centre for Technology, Innovation and Economic Research (CTIER); Dr. Jagannath Jadhav, Assistant Vice President (R&D and Business Development), Indo Amines; Dr. Maneesh Kumar Sharma, Associate Vice President - NPD/R&D, Silox India and Dr. Akshay Kant Chaturvedi, Corporate Head – IPR, Gujarat Fluorochemicals. The session will be moderated by Pravin Prashant, Executive Editor of India Chemical News, steering the dialogue toward actionable insights for policy and industry integration.
The panel will dissect six pivotal areas essential for scaling India's chemical and pharmaceutical R&D capabilities: Blended Finance and Patient Capital, Maximizing Grants and Subsidies, strengthening IP Protection, Bridging the Lab-to-Market Gap, Funding the Green Transition and Regulatory De-risking.
The chemical and pharma sectors are primary pillars of the Indian economy. As global supply chains realign, establishing a robust domestic framework for patent capital, ironclad IP laws, and seamless academy-industry collaboration will dictate India's trajectory toward becoming a global R&D superpower by 2047.